Exact Mass: 293.06188000000003
Exact Mass Matches: 293.06188000000003
Found 348 metabolites which its exact mass value is equals to given mass value 293.06188000000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
typhon
C14H16ClN3O2 (293.09309859999996)
CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9257; ORIGINAL_PRECURSOR_SCAN_NO 9255 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9197; ORIGINAL_PRECURSOR_SCAN_NO 9195 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9205; ORIGINAL_PRECURSOR_SCAN_NO 9203 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9250; ORIGINAL_PRECURSOR_SCAN_NO 9246 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4784; ORIGINAL_PRECURSOR_SCAN_NO 4780 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4767; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4773; ORIGINAL_PRECURSOR_SCAN_NO 4771 ORIGINAL_ACQUISITION_NO 4761; CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 4756 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9251; ORIGINAL_PRECURSOR_SCAN_NO 9247 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9148; ORIGINAL_PRECURSOR_SCAN_NO 9147 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4768; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4761; ORIGINAL_PRECURSOR_SCAN_NO 4756 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4740; ORIGINAL_PRECURSOR_SCAN_NO 4739 KEIO_ID T112; [MS2] KO009258 KEIO_ID T112; [MS3] KO009259 KEIO_ID T112; [MS3] KO009260 D016573 - Agrochemicals D010575 - Pesticides KEIO_ID T112
Oxaprozin
Oxaprozin is only found in individuals that have used or taken this drug. It is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.Anti-inflammatory effects of Oxaprozin are believed to be due to inhibition of cylooxygenase in platelets which leads to the blockage of prostaglandin synthesis. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Oxaprozin is a non-selective NSAID, with a cell assay system showing lower COX-2 selectivity implying higher COX-1 selectivity. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors Oxaprozin is an orally active and potent COX inhibitor, with IC50 values of 2.2 μM for human platelet COX-1 and and 36 μM for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin also inhibits the activation of NF-κB. Oxaprozin induces cell apoptosis. Oxaprozin shows anti-inflammatory activity. Oxaprozin-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties[1][2].
N-Acetylmuramate
This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group. KEIO_ID A191
[(2R,3S,4R,5R)-3,4-dihydroxy-5-pyrimidin-1-ium-1-yl-tetrahydrofuran-2-yl]methyl dihydrogen phosphate
S-(Indolylmethylthiohydroximoyl)-L-cysteine
(3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside
(3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside is found in cereals and cereal products. (3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside is a constituent of barley (Hordeum vulgare). Constituent of barley (Hordeum vulgare). (3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside is found in barley and cereals and cereal products.
Lumiracoxib
C15H13ClFNO2 (293.06188000000003)
Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug. On August 11, 2007, Australias Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
Galactosyl 4-hydroxyproline
Galactosyl 4-hydroxyproline is found in cereals and cereal products. Galactosyl 4-hydroxyproline is isolated from hydrolyzed wheat endosperm. Isolated from hydrolysed wheat endosperm. Galactosyl 4-hydroxyproline is found in cereals and cereal products.
4-Hydroxyproline galactoside
4-Hydroxyproline galactoside is found in cereals and cereal products. 4-Hydroxyproline galactoside is isolated from hydrolyzed wheat endosperm. Isolated from hydrolysed wheat endosperm. 4-Hydroxyproline galactoside is found in cereals and cereal products.
N-(2-hydroxymethyl-3-chloro-4-hydroxyphenyl)anthranilic acid
N-(2-hydroxymethyl-3-chloro-4-hydroxyphenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.
Islatravir
C12H12FN5O3 (293.09241340000005)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors
N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
N'-[(4-Oxo-4H-chromen-3-yl)methylene]nicotinohydrazide
C16H11N3O3 (293.08003759999997)
3G8CFM4T9A
Aristololactam is a natural product found in Aristolochia tubiflora, Aristolochia argentina, and other organisms with data available. Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristololactam I (AL-I) directly injures renal proximal tubule cells, the cytotoxic potency of AL-I is higher than that of AA-I and that the cytotoxic effects of these molecules are mediated through the induction of apoptosis in a caspase-3-dependent pathway[1]. Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristololactam I (AL-I) directly injures renal proximal tubule cells, the cytotoxic potency of AL-I is higher than that of AA-I and that the cytotoxic effects of these molecules are mediated through the induction of apoptosis in a caspase-3-dependent pathway[1].
Noraristolodione
Noraristolodione is a natural product found in Aristolochia elegans, Aristolochia indica, and other organisms with data available.
1-(4-Methoxybenzyl)-6,7-methylenedioxyisoquinoline
6-hydroxy-3,3-dimethyl-12H-pyrano[2,3-c]acridin-7-one
2,2,2-Trichlor-1-(4-hydroxy-2-isopropyl-5-methyl-phenyl)-aethanon-imin|2,2,2-trichloro-1-(4-hydroxy-2-isopropyl-5-methyl-phenyl)-ethanone-imine
C12H14Cl3NO (293.01409240000004)
2-acetamido-4-O-((S)-1-carboxyethyl)-2-deoxy-D-glucopyranose|2-acetamido-4-O-<(S)-1-carboxyethyl>-2-deoxy-D-glucopyranose
Indolo[3,2,1-ij]quinolino[4,5-bc][1,5]naphthyridine
6-chloro-n-(2-chlorophenyl)-1-methyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine
oxaprozin
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors Oxaprozin is an orally active and potent COX inhibitor, with IC50 values of 2.2 μM for human platelet COX-1 and and 36 μM for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin also inhibits the activation of NF-κB. Oxaprozin induces cell apoptosis. Oxaprozin shows anti-inflammatory activity. Oxaprozin-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties[1][2].
Naphthol AS-OL
CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5054; ORIGINAL_PRECURSOR_SCAN_NO 5049 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5079; ORIGINAL_PRECURSOR_SCAN_NO 5074 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5032; ORIGINAL_PRECURSOR_SCAN_NO 5030 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5075; ORIGINAL_PRECURSOR_SCAN_NO 5073 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5061; ORIGINAL_PRECURSOR_SCAN_NO 5057 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5055; ORIGINAL_PRECURSOR_SCAN_NO 5054 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9521; ORIGINAL_PRECURSOR_SCAN_NO 9519 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9583; ORIGINAL_PRECURSOR_SCAN_NO 9581 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9626; ORIGINAL_PRECURSOR_SCAN_NO 9624 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9630; ORIGINAL_PRECURSOR_SCAN_NO 9625 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9646; ORIGINAL_PRECURSOR_SCAN_NO 9645
TRIADIMEFON
C14H16ClN3O2 (293.09309859999996)
D016573 - Agrochemicals D010575 - Pesticides
Lumiracoxib
C15H13ClFNO2 (293.06188000000003)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
Galactosyl 4-hydroxyproline
4-Hydroxyproline galactoside
(3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside
2-AMINO-4-(3,4-DIMETHOXYPHENYL)THIOPHENE-3-CARBOXYLICACIDMETHYLESTER
Benserazide hydrochloride
C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C471 - Enzyme Inhibitor
Benzoic acid, 4-[(3-formyl-1H-indol-1-yl)methyl]-, methyl ester (9CI)
Benzoic acid, 4-[(3-formyl-2-methyl-1H-indol-1-yl)methyl]- (9CI)
methyl 4-(4-chlorophenyl)imino-5,5,5-trifluoropentanoate
5-tert-butoxycarbonylamino-benzo[b]thiophene-2-carboxylic acid
ETHYL 2-(3,4-DIMETHOXYPHENYL)THIAZOLE-4-CARBOXYLATE
(2E,4E)-5-PHENYL-PENTA-2,4-DIEN-1-OL
C18H15NOS (293.08743000000004)
[3-Acetyl-2-(4-fluoro-phenyl)-4-hydroxy-5-oxo-2,5-dihydro-pyrrol-1-yl]-acetic acid
5,6-DI-P-TOLYL-[1,2,4]TRIAZINE-3-THIOL
C17H15N3S (293.09866300000004)
2-(3-Methoxyphenyl)-6-methylquinoline-4-carboxylic acid
2-(2-Methoxyphenyl)-8-methylquinoline-4-carboxylic acid
2-(3-Methoxyphenyl)-8-methylquinoline-4-carboxylic acid
2-(4-Methoxyphenyl)-8-methylquinoline-4-carboxylic acid
8,9-difluoro-5-methyl-1,7-dioxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
Benzenesulfonic acid,4-methyl-, 4-nitrophenyl ester
C13H11NO5S (293.03579160000004)
2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)ANILINE DIHYDROCHLORIDE
4-(3-(Trifluoromethyl)benzoyl)-piperidine hydrochloride
ethyl 4-(4-fluorophenyl)-1-methyl-2,6-dioxopiperidine-3-carboxylate
C15H16FNO4 (293.10633079999997)
METHYL 5-(TERT-BUTYL)-1-(6-CHLOROPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBOXYLATE
C14H16ClN3O2 (293.09309859999996)
1-(1-ADAMANTYL)-2-BROMOPROPAN-1-ONE
C15H20BrN (293.07790200000005)
3-Carboxy-5-nitrobenzeneboronic acid pinacol ester
ethyl 2-[2-(4-fluorophenyl)-2-oxoethyl]-1,3-thiazole-4-carboxylate
C14H12FNO3S (293.05218940000003)
Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-4-fluoro
4-Anilino-3-nitrobenzenesulfonamide
C12H11N3O4S (293.04702460000004)
Meclofenoxate hydrochloride
C12H17Cl2NO3 (293.05854320000003)
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D020011 - Protective Agents Meclofenoxate hydrochloride is an ester synthesized from DMAE and pCPA, which has the activity of stimulating memory and improving cognition.
1-(5-(TERT-BUTYL)ISOXAZOL-3-YL)-3-(4-CHLOROPHENYL)UREA
C14H16ClN3O2 (293.09309859999996)
1-(5-(TERT-BUTYL)ISOXAZOL-3-YL)-3-(3-CHLOROPHENYL)UREA
C14H16ClN3O2 (293.09309859999996)
3-(4-NITRO-PHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE
C16H11N3O3 (293.08003759999997)
6-chloro-2-(2-cyclopentylethyl)imidazo[1,2-b]pyridazine-3-carboxylic acid
C14H16ClN3O2 (293.09309859999996)
N-(4-methylphenyl)sulfonylbenzenecarboximidoyl chloride
1-(3-MORPHOLINOPROPYL)PIPERAZINE
C11H17Cl2N3O2 (293.06977620000004)
2-Naphthalenol,1-[2-(2-nitrophenyl)diazenyl]-
C16H11N3O3 (293.08003759999997)
5,7-dichloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine
2-(4-BROMO-PHENYL)-5-TERT-BUTYL-2H-PYRAZOL-3-YLAMINE
2-(3-BROMO-PHENYL)-5-TERT-BUTYL-2H-PYRAZOL-3-YLAMINE
6-Benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine
2-(3-METHOXYPHENYL)PYRIDO[3,2:4,5]FURO[3,2-D]PYRIMIDIN-4(3H)-ONE
C16H11N3O3 (293.08003759999997)
7-Benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyriMidine
2-AMINO-1-(2,6-DICHLOROBENZYL)-4,5-DIMETHYL-1H-PYRROLE-3-CARBONITRILE
2-CHLORO-N-[(4-CHLOROPHENYL)(PHENYL)METHYL]ACETAMIDE
Methoxypolyethylene glycol 5,000 acetic acid N-succinimidyl ester
4-bromo-N-(4-fluorobenzyl)-2-methylaniline
C14H13BrFN (293.02153300000003)
(3-nitrophenyl) 4-methylbenzenesulfonate
C13H11NO5S (293.03579160000004)
Ethyl 5-chloro-3-(4-methoxyphenyl)-1,2,4-triazine-6-carboxylate
2-Bromo-N-methyl-1-adamantanemethanamine hydrochloride
C12H21BrClN (293.05457960000007)
Piperidin-4-yl (2-(trifluoromethyl)phenyl)methanone hydrochloride
(3,4-Dichlorophenyl)(piperidin-4-yl)methanone hydrochloride
C12H14Cl3NO (293.01409240000004)
5-amino-1,2,3-thiadiazole-n-phenoxycarbonyl-4-carboxylic acid ethyl ester
C12H11N3O4S (293.04702460000004)
1-Benzyl-4-bromo-3-methyl-1H-pyrazole-5-carboxamide
(S)-3-BENZYLOXYCARBONYL-5-OXO-4-OXAZOLIDINEPROPANOIC ACID
2-CHLORO-N-(4-METHOXYBENZYL)-3-NITROPYRIDIN-4-AMINE
(2E)-3-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylacryla mide
1H-INDOL-3-YL[3-(4-METHOXYPHENYL)OXIRAN-2-YL]METHANONE
5(4H)-Oxazolone,4-(1,3-benzodioxol-5-ylmethylene)-2-phenyl-
methyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
C11H16ClNO4S (293.04885260000003)
trans-3-Ethoxycarbonyl-4-(4-flurophenyl)-N-methyl piperdine-2,6-dione
C15H16FNO4 (293.10633079999997)
(S)-1,4-Diazabicyclo[4.3.0]nonane
C10H10ClF6N (293.04059220000005)
N-(4-Chlorobenzylidene)-4-methylbenzenesulfonamide
1-[3,5-Bis(trifluoromethyl)phenyl]ethanamine Hydrochloride
C10H10ClF6N (293.04059220000005)
ethyl 3-(2-carboxy-vinyl)-5-chloro-1h-indole-2-carboxylate
4-(2,4-dichlorophenoxy)butyric acid, compound with dimethylamine (1:1)
C12H17Cl2NO3 (293.05854320000003)
(4S)-2-[2-(Trifluoromethoxy)phenyl]-1,3-thiazolidine-4-carboxylic acid
(R)-Methyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
C11H16ClNO4S (293.04885260000003)
MK-8591
C12H12FN5O3 (293.09241340000005)
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
(3-((3-CHLORO-4-FLUOROPHENYL)CARBAMOYL)PHENYL)BORONIC ACID
C13H10BClFNO3 (293.04262620000003)
1-(2-NAPHTHALENYL)-1H-PYRROLE-2,5-DIONE
C11H17Cl2N3O2 (293.06977620000004)
1-[4-(Trifluoromethyl)pyrimidin-2-yl]piperidine-4-carbonyl chloride
ethyl 1-cyclopropyl-6,7-difluoro-4-oxoquinoline-3-carboxylate
ethyl 2-(4-amino-3-methoxyphenyl)-3,3,3-trifluoro-2-hydroxypropanoate
8-ETHOXYQUINOLINE-5-SULFONIC ACID SODIUM SALT HEMIHYDROATE
[2-(3-bromo-phenyl)-ethyl]-(4-fluoro-phenyl)-amine
C14H13BrFN (293.02153300000003)
3-NITRO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOIC ACID
5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine
(1S)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one
C14H16ClN3O2 (293.09309859999996)
1-(2-Chlorophenyl)-2-(3,5-dimethyl-4-nitro-1-pyrazolyl)ethanone
2-Chloro-3-pyridinecarboxylic acid [2-(4-fluorophenyl)-2-oxoethyl] ester
3-(4-Azidobenzyl)-4-hydroxycoumarin
C16H11N3O3 (293.08003759999997)
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
6-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
9-Amino-5-(2-aminopyrimidin-4-yl)pyrido[3,2:4,5]pyrrolo[1,2-c]pyrimidin-4-ol
4-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-1,7-dihydroxy-2,3,5-trioxabicyclo[2.2.2]oct-7-en-6-one
1-(4-Chlorophenoxy)-3,3-dimethyl-1-(triazol-2-yl)butan-2-one
C14H16ClN3O2 (293.09309859999996)
(2R)-2-amino-3-[(E)-N-hydroxy-C-(1H-indol-3-ylmethyl)carbonimidoyl]sulfanylpropanoic acid
(E)-1-(L-cystein-S-yl)-N-hydroxy-2-(1H-indol-3-yl)ethan-1-imine
N,N-diethyl-4-[hydroxy(sulfanyl)phosphinothioyl]oxy-6-methylpyrimidin-2-amine
3-nitro-N-(pyridin-4-ylmethyl)benzenesulfonamide
C12H11N3O4S (293.04702460000004)
N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide
3-[5-Amino-3-(4-chlorophenyl)-1-pyrazolyl]propanoic acid ethyl ester
C14H16ClN3O2 (293.09309859999996)
3,4-dichloro-N-[(E)-pyridin-2-ylmethylideneamino]benzamide
3-(4-Methylphenyl)sulfonyl-3-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid
N-(4-hydroxyphenyl)-3-methoxy-2-naphthalenecarboxamide
(2R)-2-amino-3-[(Z)-N-hydroxy-C-(1H-indol-3-ylmethyl)carbonimidoyl]sulfanylpropanoic acid
2-Butanone, 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-, (1R)-
C14H16ClN3O2 (293.09309859999996)
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide
3-Amino-4-[(4-chlorophenyl)thio]benzoic acid methyl ester
1-Ethyl-3-[(5-nitro-2-oxo-3-indolyl)amino]thiourea
C11H11N5O3S (293.05825760000005)
3-hydroxy-7-methyl-3-(4-morpholinyl)-5-nitro-1H-indol-2-one
4-methyl-N,5-diphenyl-3-thiophenecarboxamide
C18H15NOS (293.08743000000004)
3-(Phenylmethyl)-6-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
1-[4-(4-Chlorophenyl)thiazol-2-yl]-2-(pentan-3-ylidene)hydrazine
4-methylbenzoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester
6-chloro-5,7-dimethyl-N-(thiophen-2-ylmethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine
C12H12ClN5S (293.05019020000003)
3-[1-(3-Methoxypropyl)-5-thiophen-2-yl-2-pyrrolyl]propanoic acid
N-[(4-chlorophenyl)methyl]-2-(2,4-dioxo-1H-pyrimidin-6-yl)acetamide
3-(4-Methylphenyl)-6-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
3-methyl-N,1-diphenyl-4-pyrazolecarbothioamide
C17H15N3S (293.09866300000004)
1-[2-(4-Morpholinyl)-2-oxoethyl]-2-pyrido[2,3-b][1,4]thiazinone
2-[[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)-4-oxanyl]oxy]propanoic acid
4-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidine-2-carboxylic acid
1-S-(N-hydroxypent-4-enimidoyl)-1-thio-beta-D-glucopyranose
6-Methyl-3-[2-(4-methylphenyl)-2-oxoethyl]-1,4-benzoxazin-2-one
4-Acetyl-5-(4-fluorophenyl)-1-(2-methoxyethyl)pyrrolidine-2,3-dione
C15H16FNO4 (293.10633079999997)
trans-2-Hexenal oxime, o-[(pentafluorophenyl)methyl]-
N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
2-[3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid
3-butenyldesulfoglucosinolate
A desulfoglucosinolic acid resulting from the formal condensation of the thiol group of N-hydroxypent-4-enethioamide with beta-D-glucopyranose.
9-hydroxy-2,2-dimethyl-11h-pyrano[2,3-a]carbazole-8-carbaldehyde
5-chloro-10,12-dihydroxy-11-propyl-2-oxa-7-azatricyclo[7.4.0.0³,⁷]trideca-1(13),3,5,9,11-pentaen-8-one
11-hydroxy-2,2-dimethyl-5h-1-oxa-5-azatetraphen-10-one
(2s,3r,4s,4ar,11br)-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridine-2,3,4,6-tetrol
13-methyl-3,5,8-trioxa-13-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹⁴,¹⁹]icosa-1(12),2(6),7(11),9,14,16,18-heptaen-20-one
(2r,3r,5s,6s)-3,5-dihydroxy-2-(hydroxymethyl)-6-(1h-indol-3-yloxy)oxan-4-one
(2r)-2-amino-3-{[(1z)-1-(hydroxyimino)-2-(1h-indol-3-yl)ethyl]sulfanyl}propanoic acid
2-{[1-(hydroxyimino)pent-4-en-1-yl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol
(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene-11-carbaldehyde
3,3-dihydroxy-2-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile
aristolactam iiia; me ether
{"Ingredient_id": "HBIN016777","Ingredient_name": "aristolactam iiia; me ether","Alias": "NA","Ingredient_formula": "C17H11NO4","Ingredient_Smile": "NA","Ingredient_weight": "293.27","OB_score": "NA","CAS_id": "81451-90-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6666","PubChem_id": "NA","DrugBank_id": "NA"}
(2e)-3-[5-(acetyloxy)-4,5-dihydrofuran-3-yl]-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)prop-2-enimidic acid
(12s)-18-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),9,14,16,18-heptaen-13-one
18-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),9,14,16,18-heptaen-13-one
10-methoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one
2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid
15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-11,12-dione
14-methoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol
17-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-1(18),2(10),3,8,13,15(19),16-heptaen-11-one
2-[(1-{[2-(c-hydroxycarbonimidoyl)phenyl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]acetic acid
5-[(4-methoxyphenyl)methyl]-2h-[1,3]dioxolo[4,5-g]isoquinoline
3,3,8-trimethyl-11h-pyrano[3,2-a]carbazole-7,10-dione
8,14-dihydroxy-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one
C16H11N3O3 (293.08003759999997)